Jung, Daniel and Strom, David

Antibiotic resistance has remained a topic of concern, and most current treatments prioritize preventing infections from antibiotic resistant pathogens. Hence, finding new antimicrobial compounds to suppress or rid of pathogens...

Poster

Rudie, Melissa, Cornett, Megan, Przybelski, Samantha, Ulloa, Massiel, and Strom, David

Troglitazone (TRO), a peroxisome proliferator-activated receptor (PPAR) agonist, was a drug used as an anti-inflammatory and anti-diabetic agent. We had previously investigated a PPAR agonist that induced apoptosis in dose...

poster

Ristic, M., Rahman, R., Boncher, T., Gleason, S., Brinkman, H., Fein, A., Do, A., and Strom, David

Development of new and highly tailored chemotherapeutic agents continues to be the mainstay for innovative clinical treatment of cancer. Peroxisome proliferator-activated receptors (PPARs), part of a nuclear hormone super...

poster